Scope Investment is committed to enhancing healthcare access and specialized services in the Middle East and beyond. Partnering with Asan Medical Center, Scope is building the UAE’s first comprehensive GI hospital, enhancing regional healthcare with advanced treatments. Additionally, its Medical Devices Production Plant in Egypt will begin producing auto-disable syringes in 2025, contributing to safer and sustainable healthcare practices in the Middle East.
Scope Investment partnered with Asan Medical Center (AMC), the largest and foremost hospital in South Korea, to open GCC’s first comprehensive GI (gastroenterology) hospital in the UAE. The hospital, under construction as of 2023, will be the first global hospital for Asan outside of South Korea. The joint venture brings global standards of specialized healthcare to the region, with a focus on:
With the rising demand for reproductive services, Scope Healthcare has developed a roadmap to make sophisticated fertility treatments available throughout the MENA region. It will introduce specialized in-vitro fertilization (IVF) procedures through a comprehensive network of IVF clinics that will operate under the name Life Fertility. This roadmap aligns with Scope Investment’s broader strategy of nurturing investments for a sustainable future in the MENA region and beyond.
Following world-class methodologies and upholding the highest standards in processes and policies, the network will provide a cohesive ecosystem to ensure that those seeking fertility solutions receive cutting-edge medical treatment and assistance on their path to parenthood.
With its commitment to delivering quality and excellence in healthcare offerings, Scope Healthcare is increasing capacity through manufacturing.
Its medical devices production plant in Egypt will launch its first phase in the middle of 2025 with a manufacturing line of the auto disable (AD) syringes, designed to prevent syringe reuse, thereby preventing the transmission of pathogens between patients. Following the production of AD syringes, other medical devices are planned.
As Africa’s population grows, so do the critical gaps in immunization. Recognizing the urgency of this public health challenge, Scope Healthcare is strategically poised to bridge such gaps by establishing a vaccine manufacturing facility in Egypt.
This healthcare offering aligns with the company’s commitment to advancing healthcare infrastructure and strengthens its role in building sustainable health solutions for the future.